CPo3604-01
CPo3604-01 Basic information
- Product Name:
- CPo3604-01
- Synonyms:
-
- CPo3604-01
- tert-butyl [(2R,3S)-5-oxo-2-(2,5-difluorophenyl)tetradihydro-2H-pyran-3-yl]carbaMate
- tert-butyl [(2R,3S)-2-(2,5-difluorophenyl)-5-oxotetrahydro-2H-pvran-3 yl]carbaMate
- tert-butyl ((2R,3S)-2-(2,5-difluorophenyl)-5-oxotetrahydro-2H-pyran-3-yl)carbaMate
- N-[(2R,3S)-2-(2,5-difluorophenyl)tetrahydro-5-oxo-2H-pyran-3-yl]-CarbaMic acid 1,1-diMethylethyl ester
- Omarigliptin inter. OG-1
- Product NaMe:MK-3102 interMediate
- Carbamic acid, N-[(2R,3S)-2-(2,5-difluorophenyl)tetrahydro-5-oxo-2H-pyran-3-yl]-, 1,1-dimethylethyl ester
- CAS:
- 951127-25-6
- MF:
- C16H19F2NO4
- MW:
- 327.32
- Product Categories:
-
- MK-3102 intermediate
- Mol File:
- 951127-25-6.mol
More
Less
CPo3604-01 Chemical Properties
- Boiling point:
- 433.4±45.0 °C(Predicted)
- Density
- 1.25±0.1 g/cm3(Predicted)
- storage temp.
- 2-8°C
- pka
- 11.00±0.40(Predicted)
More
Less
CPo3604-01 Usage And Synthesis
Uses
N-[(2R,3S)-2-(2,5-Difluorophenyl)tetrahydro-5-oxo-2H-pyran-3-yl]carbamic Acid 1,1-Dimethylethyl Ester is a useful synthetic intermediate in the synthesis of Omarigliptin (O633100); a potent and selective dipeptidyl peptidase 4 (DPP-4) inhibitor used for the treatment of type 2 diabetes.
CPo3604-01Supplier
ShangHai Caerulum Pharma Discovery Co., Ltd. Gold
- Tel
- 18149758185 18149758185
- sales-cpd@caerulumpharma.com
Zhongshan Haihong Medicine Co. Ltd Gold
- Tel
- 0760-86925768 18824993998
- seas168@126.com
Shanghai Pansopharm Technology Co., Ltd. Gold
- Tel
- 021-20962833 15316628753
- sales@pansopharm.com
Zhengzhou Converging Chemical Co. LTD Gold
- Tel
- 0371-0371-53399770 18037166334
- 2853031800@qq.com
Chengdu D-innovation Pharmaceutical Co.,LTD Gold
- Tel
- 028-85105512 17802830247
- baozuqiang@d-innovation.com
More
Less
CPo3604-01(951127-25-6)Related Product Information
- 2-Pyrrolidinone, 5-([1,1'-biphenyl]-4-ylMethyl)-3-Methyl-, (3R,5S)-
- AHU-377
- (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine (2R)-Hydroxy(phenyl)ethanoate
- 2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene
- TICAGRELOR
- Ethanol, 2-[[(3aR,4S,6R,6aS)-6-[[5-aMino-6-chloro-2-(propylthio)-4-pyriMidinyl]aMino]tetrahydro-2,2-diMethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-
- Canagliflozin heMihydrate
- 8-bromo-7-(but-2-ynyl)-3-methyl-1H-purine-2,6(3H,7H)-dione
- (1R trans)-2-(3,4-difluorophenyl)cyclopropane amine
- Tetrahydro-2,2-dimethyl-4,7-methano-6H-1,3-dioxolo[4,5-d][1,2]oxazine-6-carboxylic acid phenylmethyl ester
- Canagliflozin
- Cyclopropanamine,2-(3,4-difluorophenyl)-(1R,2S) -(2R,3R)-2,3-dihydroxybutanedioate (1:1)
- Pyrrolo[3,4-c]pyrazole-5(1H)-carboxylic acid, 4,6-dihydro-, 1,1-dimethylethyl ester
- 2-(Methylsulfonyl)-2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole
- tert-butyl 2-(Methylsulfonyl)-4,6-dihydropyrrolo[3,4-c]pyrazole-5(2H)-carboxylate
- tert-butyl 1-(2,5-difluorophenyl)-1-oxopent-4-yn-2-ylcarbaMate
- 1-(2-chloro-4-hydroxyphenyl)-3-cyclopropylurea
- Piperazine, 1-(cyclopropylcarbonyl)-, Monohydrochloride